Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
4.320
-0.200 (-4.42%)
At close: Mar 30, 2026, 4:00 PM EDT
4.390
+0.070 (1.62%)
Pre-market: Mar 31, 2026, 8:37 AM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $216.15 million as of March 31, 2026. Its market cap has increased by 35.74% in one year.
Market Cap
216.15M
Enterprise Value
21.03M
1-Year Change
35.74%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $216.15M, an increase of 137.28%. That is a compound annual growth rate of 17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 216.15M | -47.05% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 229.31M |
| OmniAb | 225.86M |
| Context Therapeutics | 225.10M |
| Sol-Gel Technologies | 224.06M |
| Alector | 222.93M |
| Akari Therapeutics, | 219.10M |
| Editas Medicine | 218.25M |
| Enlivex | 213.64M |